Neodymium: YAG transscleral cyclocoagulation: a clinical study.
Thirty-seven eyes of 35 patients with uncontrolled glaucoma on maximum medication and after previous failed glaucoma surgery, were treated by transscleral cyclocoagulation using the free running mode of the Lasag Microrupter II Neodymium: YAG (Nd:YAG) laser. The indications, technique and results are discussed in this group of complicated glaucomatous eyes and suggests that Nd:YAG laser cyclocoagulation is a safe and effective method of lowering the intraocular pressure (IOP) and improving glaucoma control. The mean pre-treatment IOP was 41 mmHg, and the mean post-operative IOP was 22.5 mmHg. The post-operative IOP was 25 mmHg or less in 27 of 37 eyes (73%) after an average follow-up of eight months.
McAllister
J
J
Prince Charles Eye Unit, King Edward VII Hospital, Windsor, Berks.
O'Brien
C
C
D000293:Adolescent; D000328:Adult; D000368:Aged; D002924:Ciliary Body / Q000601:surgery; D003229:Conjunctival Diseases / Q000209:etiology; D004487:Edema / Q000209:etiology; D005260:Female; D005901:Glaucoma / Q000601:surgery*; D006801:Humans; D053685:Laser Therapy / Q000379:methods*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000209:etiology; D014605:Uveitis / Q000209:etiology